December 21, 2017 / 1:37 PM / in 2 months

BRIEF-XSpray Pharma Enters Manufacturing Agreement With NerPharMa

Dec 21 (Reuters) - Xspray Pharma Ab (Publ):

* XSPRAY PHARMA ENTERS MANUFACTURING AGREEMENT WITH NERPHARMA FOR ITS LEAD PRODUCT CANDIDATE; HYNAP-DASA

* COMPANY‘S GOAL IS TO LAUNCH HYNAP-DASA IN US-MARKET IN 2021. Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below